[ Price : $8.95]
FDA approves a second breakthrough-designated drug Pharmacyclics and Janssen Biotechs Imbruvica (ibrutinib) for treating patients...[ Price : $8.95]
Sen. Tom Harkin says the Senate will debate his Drug Quality and Security Act on oversight of drug compounding and a national drug...[ Price : $8.95]
Policy and Medicine urges regulated industry to study new compliance integrity agreements to keep up with enforcement trends.[ Price : $8.95]
FDA grants conditional approval to PresbiBio LLC for an IDE application to begin a Phase 2 trial of its Presbia Flexivue Microlens...[ Price : $8.95]
Federal Register Proposed rule: FDA proposes to revise procedures for approved drug or biological product holders to change labeli...[ Price : $8.95]
FDA commissioner Margaret Hamburg says her agency is working with Mekong Region counterparts on issues of food and drug safety.[ Price : $8.95]
CDER medical reviewers tell the Peripheral and Central Nervous System Advisory Committee that they recommend approval of Vanda Pha...[ Price : $8.95]
GlaxoSmithKline says its darapladib failed to meet the primary endpoint in a Phase 3 trial of its use in adults with chronic coron...